The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.
O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, Gascoyne RD, Wright G, Staudt LM, Lister TA, Fitzgibbon J.
O'Shea D, et al. Among authors: taylor c.
Blood. 2008 Oct 15;112(8):3126-9. doi: 10.1182/blood-2008-05-154013. Epub 2008 Jul 15.
Blood. 2008.
PMID: 18628487
Free PMC article.